345 related articles for article (PubMed ID: 15466983)
41. Cancer anorexia-cachexia syndrome: are neuropeptides the key?
Inui A
Cancer Res; 1999 Sep; 59(18):4493-501. PubMed ID: 10493494
[TBL] [Abstract][Full Text] [Related]
42. Rethinking nutritional support for persons with cancer cachexia.
McCarthy DO
Biol Res Nurs; 2003 Jul; 5(1):3-17. PubMed ID: 12886666
[TBL] [Abstract][Full Text] [Related]
43. Reactive oxygen species, antioxidant mechanisms and serum cytokine levels in cancer patients: impact of an antioxidant treatment.
Mantovani G; Macciò A; Madeddu C; Mura L; Massa E; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L
J Cell Mol Med; 2002; 6(4):570-82. PubMed ID: 12611641
[TBL] [Abstract][Full Text] [Related]
44. Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia.
Mantovani G; Macciò A; Madeddu C; Serpe R; Antoni G; Massa E; Dessì M; Panzone F
J Mol Med (Berl); 2010 Jan; 88(1):85-92. PubMed ID: 19802504
[TBL] [Abstract][Full Text] [Related]
45. [Pharmacological therapy of cancer anorexia-cachexia].
Cardona D
Nutr Hosp; 2006 May; 21 Suppl 3():17-26. PubMed ID: 16768027
[TBL] [Abstract][Full Text] [Related]
46. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
47. Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.
Persson C; Glimelius B; Rönnelid J; Nygren P
Nutrition; 2005 Feb; 21(2):170-8. PubMed ID: 15723745
[TBL] [Abstract][Full Text] [Related]
48. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group.
Bozzetti F; Mariani L
JPEN J Parenter Enteral Nutr; 2009; 33(4):361-7. PubMed ID: 19109514
[TBL] [Abstract][Full Text] [Related]
49. Anorexia-cachexia syndrome: a systematic review of the role of dietary polyunsaturated Fatty acids in the management of symptoms, survival, and quality of life.
Mazzotta P; Jeney CM
J Pain Symptom Manage; 2009 Jun; 37(6):1069-77. PubMed ID: 19054647
[TBL] [Abstract][Full Text] [Related]
50. Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia.
Chasen M; Hirschman SZ; Bhargava R
J Am Med Dir Assoc; 2011 Jan; 12(1):62-7. PubMed ID: 21194662
[TBL] [Abstract][Full Text] [Related]
51. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome.
Edelman MJ; Gandara DR; Meyers FJ; Ishii R; O'Mahony M; Uhrich M; Lauder I; Houston J; Gietzen DW
Cancer; 1999 Aug; 86(4):684-8. PubMed ID: 10440697
[TBL] [Abstract][Full Text] [Related]
52. The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: correlation with disease progression.
Mantovani G; Macciò A; Madeddu C; Mura L; Gramignano G; Lusso MR; Murgia V; Camboni P; Ferreli L; Mocci M; Massa E
Free Radic Res; 2003 Feb; 37(2):213-23. PubMed ID: 12653210
[TBL] [Abstract][Full Text] [Related]
53. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides.
Ramos EJ; Suzuki S; Marks D; Inui A; Asakawa A; Meguid MM
Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):427-34. PubMed ID: 15192446
[TBL] [Abstract][Full Text] [Related]
54. Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
Mantovani G; Macciò A; Madeddu C; Serpe R; Massa E; Dessì M; Panzone F; Contu P
Oncologist; 2010; 15(2):200-11. PubMed ID: 20156909
[TBL] [Abstract][Full Text] [Related]
55. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome.
Plata-Salamán CR
Nutrition; 2000 Oct; 16(10):1009-12. PubMed ID: 11054608
[TBL] [Abstract][Full Text] [Related]
56. Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management.
Gadducci A; Cosio S; Fanucchi A; Genazzani AR
Anticancer Res; 2001; 21(4B):2941-7. PubMed ID: 11712791
[TBL] [Abstract][Full Text] [Related]
57. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study.
Bruera E; Strasser F; Palmer JL; Willey J; Calder K; Amyotte G; Baracos V
J Clin Oncol; 2003 Jan; 21(1):129-34. PubMed ID: 12506181
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of Anorexia Cancer Cachexia Syndrome and Potential Benefits of Traditional Medicine and Natural Herbs.
Ming-Hua C; Bao-Hua Z; Lei Y
Curr Pharm Biotechnol; 2016; 17(13):1147-1152. PubMed ID: 27758689
[TBL] [Abstract][Full Text] [Related]
59. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites.
Mantovani G; Macciò A; Mura L; Massa E; Mudu MC; Mulas C; Lusso MR; Madeddu C; Dessì A
J Mol Med (Berl); 2000; 78(10):554-61. PubMed ID: 11199328
[TBL] [Abstract][Full Text] [Related]
60. Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia.
Mantovani G; Madeddu C
Curr Opin Support Palliat Care; 2008 Dec; 2(4):275-81. PubMed ID: 19069312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
